Ovid Therapeutics Inc. Common Stock
$2.68
-$0.03 (-1.11%)
$2.65Day Range$2.77
Key Statistics
Market Cap
$523.40M
Shares Outstanding
195.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 5, 2017
Round Lot
100
Locale
US
Trading Data
Day Open
$2.72
Day High
$2.77
Day Low
$2.65
Volume
1.43M
VWAP
$2.71
Prev Close
$2.71
Transactions
--
Acc. Volume
--
About Ovid Therapeutics Inc. Common Stock
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
PHARMACEUTICAL PREPARATIONSSIC 283423 employees441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001212-776-4381IPO May 5, 2017US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001636651
- Composite FIGI
- BBG009F0TD76
- Share Class FIGI
- BBG009F0TD85
- Ticker Root
- OVID
- SIC Code
- 2834
About Ovid Therapeutics Inc. Common Stock (OVID) Stock
Ovid Therapeutics Inc. Common Stock (OVID) closed the 2026-09-16 session at $2.68, down 1.11% versus the previous close (-0.03). The stock opened at $2.72 and traded between $2.65 and $2.77 during that session. Session trading volume was 1.4M shares. The volume-weighted average price (VWAP) is $2.71.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Ovid Therapeutics Inc. Common Stock has a market capitalization of $523.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. OVID is listed on the XNAS exchange. The company employs approximately 23 people. Ovid Therapeutics Inc. Common Stock is headquartered in NEW YORK, NY. The recorded listing date is 2017-05-05.
On this page you can find market OVID stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.